Diffuse cutaneous systemic sclerosis (“dcSSc”) is a rare, progressive autoimmune disease characterized by immune activation, vasculopathy and fibrosis affecting the skin and internal organs, including ...

The findings suggest that tapering could help GLP-1 users reduce their medical bills while maintaining their weight loss.

A growing body of research has looked at GLP-1 drugs for alcohol use disorder. A new study shows the medications could have a ...

A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction—and help people who already have one, a new study shows.

Statistically significant (p<0.0001) and clinically meaningful improvement in Hamilton Anxiety Rating Scale (“HAM-A”) of ~10 ...

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics ...

Medicare beneficiaries 65 years and older who participated in five to six weeks of cognitive speed training with follow-up sessions three years later were less likely to be diagnosed with Alzheimer's ...

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that blocks activin signaling pathways, results in greater weight loss while also ...

Learn the distinctions between simple and stratified random sampling. Understand how researchers use these methods to accurately represent data populations.

fDepartment of PA Studies, Wake Forest University School of Medicine, Winston-Salem, NC, United States gDepartment of Epidemiology and Prevention, Wake Forest University School of Medicine, ...